156 related articles for article (PubMed ID: 38661126)
1. Elucidating the chain of command: our current understanding of critical target genes for p53-mediated tumor suppression.
Indeglia A; Murphy ME
Crit Rev Biochem Mol Biol; 2024; 59(1-2):128-138. PubMed ID: 38661126
[No Abstract] [Full Text] [Related]
2. Combined absence of TRP53 target genes ZMAT3, PUMA and p21 cause a high incidence of cancer in mice.
Brennan MS; Brinkmann K; Romero Sola G; Healey G; Gibson L; Gangoda L; Potts MA; Lieschke E; Wilcox S; Strasser A; Herold MJ; Janic A
Cell Death Differ; 2024 Feb; 31(2):159-169. PubMed ID: 38110554
[TBL] [Abstract][Full Text] [Related]
3. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
[TBL] [Abstract][Full Text] [Related]
4. Combined loss of PUMA and p21 accelerates c-MYC-driven lymphoma development considerably less than loss of one allele of p53.
Valente LJ; Grabow S; Vandenberg CJ; Strasser A; Janic A
Oncogene; 2016 Jul; 35(29):3866-71. PubMed ID: 26640149
[TBL] [Abstract][Full Text] [Related]
5. p53 and Tumor Suppression: It Takes a Network.
Boutelle AM; Attardi LD
Trends Cell Biol; 2021 Apr; 31(4):298-310. PubMed ID: 33518400
[TBL] [Abstract][Full Text] [Related]
6. Of the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas AF; Kelly GL; Strasser A
Cell Death Differ; 2022 May; 29(5):961-971. PubMed ID: 35396345
[TBL] [Abstract][Full Text] [Related]
7. Zmat3 Is a Key Splicing Regulator in the p53 Tumor Suppression Program.
Bieging-Rolett KT; Kaiser AM; Morgens DW; Boutelle AM; Seoane JA; Van Nostrand EL; Zhu C; Houlihan SL; Mello SS; Yee BA; McClendon J; Pierce SE; Winters IP; Wang M; Connolly AJ; Lowe SW; Curtis C; Yeo GW; Winslow MM; Bassik MC; Attardi LD
Mol Cell; 2020 Nov; 80(3):452-469.e9. PubMed ID: 33157015
[TBL] [Abstract][Full Text] [Related]
8. Repression of p53-target gene Bbc3/PUMA by MYSM1 is essential for the survival of hematopoietic multipotent progenitors and contributes to stem cell maintenance.
Belle JI; Petrov JC; Langlais D; Robert F; Cencic R; Shen S; Pelletier J; Gros P; Nijnik A
Cell Death Differ; 2016 May; 23(5):759-75. PubMed ID: 26768662
[TBL] [Abstract][Full Text] [Related]
9. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?
Aubrey BJ; Kelly GL; Janic A; Herold MJ; Strasser A
Cell Death Differ; 2018 Jan; 25(1):104-113. PubMed ID: 29149101
[TBL] [Abstract][Full Text] [Related]
10. Effects of TP53 mutational status on gene expression patterns across 10 human cancer types.
Parikh N; Hilsenbeck S; Creighton CJ; Dayaram T; Shuck R; Shinbrot E; Xi L; Gibbs RA; Wheeler DA; Donehower LA
J Pathol; 2014 Apr; 232(5):522-33. PubMed ID: 24374933
[TBL] [Abstract][Full Text] [Related]
11. Chromium-mediated apoptosis: involvement of DNA-dependent protein kinase (DNA-PK) and differential induction of p53 target genes.
Hill R; Leidal AM; Madureira PA; Gillis LD; Waisman DM; Chiu A; Lee PW
DNA Repair (Amst); 2008 Sep; 7(9):1484-99. PubMed ID: 18602874
[TBL] [Abstract][Full Text] [Related]
12. Understanding the non-canonical pathways involved in p53-mediated tumor suppression.
Hager KM; Gu W
Carcinogenesis; 2014 Apr; 35(4):740-6. PubMed ID: 24381013
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the p53 family network by RNA-binding proteins.
Lucchesi C; Zhang J; Chen X
Transl Cancer Res; 2016 Dec; 5(6):676-684. PubMed ID: 28794999
[TBL] [Abstract][Full Text] [Related]
14. An African-Specific Variant of TP53 Reveals PADI4 as a Regulator of p53-Mediated Tumor Suppression.
Indeglia A; Leung JC; Miller SA; Leu JI; Dougherty JF; Clarke NL; Kirven NA; Shao C; Ke L; Lovell S; Barnoud T; Lu DY; Lin C; Kannan T; Battaile KP; Yang THL; Batista Oliva I; Claiborne DT; Vogel P; Liu L; Liu Q; Nefedova Y; Cassel J; Auslander N; Kossenkov AV; Karanicolas J; Murphy ME
Cancer Discov; 2023 Jul; 13(7):1696-1719. PubMed ID: 37140445
[TBL] [Abstract][Full Text] [Related]
15. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression.
Brady CA; Jiang D; Mello SS; Johnson TM; Jarvis LA; Kozak MM; Kenzelmann Broz D; Basak S; Park EJ; McLaughlin ME; Karnezis AN; Attardi LD
Cell; 2011 May; 145(4):571-83. PubMed ID: 21565614
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivo.
Klimovich B; Stiewe T; Timofeev O
Cell Cycle; 2020 Jan; 19(1):109-123. PubMed ID: 31749402
[No Abstract] [Full Text] [Related]
17. A systematic review of p53 regulation of oxidative stress in skeletal muscle.
Beyfuss K; Hood DA
Redox Rep; 2018 Dec; 23(1):100-117. PubMed ID: 29298131
[TBL] [Abstract][Full Text] [Related]
18. PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis.
Gnanapradeepan K; Indeglia A; Stieg DC; Clarke N; Shao C; Dougherty JF; Murali N; Murphy ME
J Biol Chem; 2022 Dec; 298(12):102637. PubMed ID: 36309086
[TBL] [Abstract][Full Text] [Related]
19. Deciphering p53 signaling in tumor suppression.
Mello SS; Attardi LD
Curr Opin Cell Biol; 2018 Apr; 51():65-72. PubMed ID: 29195118
[TBL] [Abstract][Full Text] [Related]
20. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
